Proteins are key biomolecular substances involved in all activities of the human body. To create a digital cell map that can be used throughout the ...

for which he shared the 2016 Nobel Prize in chemistry, died on Dec 30 in Melbourne, Australia. He was 82. Dr Alison Margaret Stoddart, his daughter, said he died of cardiac arrest at a hotel while ...

the DeepMind spin-off launched in 2021 by Demis Hassabis, coinventor of the protein-folding software AlphaFold and a winner of the 2024 Nobel Prize in Chemistry. Now, Marshall says, Novartis’s ...

He grew up playing with model construction sets. As an adult, he tinkered with molecules instead, creating nanomachines and winning a Nobel Prize. By Dylan Loeb McClain J. Fraser Stoddart, a ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.Most Read ...

New Jersey-based biotechnology company, Grignard Pure LLC, a leader in developing next-generation indoor air treatment solutions for disease mitigation, indoor air quality and pandemic response, is ...

As the Paris AI Action Summit starts on February 10, 2025, the EU’s exemplary record on regulating AI and data protection ...

who received the Nobel Prize for chemistry with his colleague John Jumper and biochemist David Baker in October. Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.

It’s not the first time Johnson’s pursuit of immortality has made the news. The 47-year-old allegedly spends about $2 million ...

A fledgling Chinese startup led by a hedge fund manager built a coherent AI chatbot in a year, after it took cash-flush ...